Alterity Therapeutics ATHE Income Statement (2009-2025)

NASDAQ ATHE
$4.67 +0.22 (+4.94%)
As of: Aug 21, 2026 · 3:59 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2009 Dec2009 Jun2010 Dec2010 Jun2011 Dec2011 Jun2012 Dec2012 Jun2013 Dec2013 Jun2014 Dec2014 Jun2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Shares Outstanding (Entity) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.06B0.09B0.16B
Revenue & cost
Revenue (Quarter)
0.00B-0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.01B
Gross Profit (Quarter)
-224808089.60B
Operating items
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)
0.00B-0.00B-0.00B0.00B-0.01B-0.01B-0.01B-0.01B-0.01B
Wages, Salaries and Other (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative (Quarter)
0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Rent Expense (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B
Restructuring Costs (Quarter)
0.00B0.00B0.11B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Operating Expenses (Quarter)
0.00B-0.00B0.00B0.00B
Operating Expenses (Quarter)
0.00B-0.00B0.11B-0.01B0.00B-0.01B-0.01B-0.01B-0.01B-0.01B
Operating Income (Quarter)
-0.00B
EBIT (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B
Non Operating Income (Quarter)
Net income details
Tax Provisions (Quarter)
0.11B
EBT (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Profit After Tax (Quarter)
-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Income from Non-Controlling Interests (Quarter)
-0.00B-0.00B-0.00B-0.00B
Income from Continuing Operations (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Consolidated Net Income (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Income towards Parent Company (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Net Income towards Common Stockholders (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Additional items
EPS (Basic) (Quarter)
-0.05-0.10-0.05-0.12-0.07-0.14-0.04-0.040.000.00
EPS (Diluted) (Quarter)
-1.01-1.98-1.02-2.34-1.41-3.24-1.42-0.040.000.00
Shares Outstanding (Quarter)
0.05B0.05B0.05B0.05B0.05B0.05B0.06B0.09B0.09B0.13B0.17B0.24B0.24B0.24B2.43B2.43B3.65B3.65B6.40B6.40B
Shares Outstanding (Diluted) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.09B0.09B0.17B0.17B0.24B0.24B2.43B2.43B3.65B3.65B6.40B6.40B
EBITDA (Quarter)
-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Interest Expenses (Quarter)
0.00B
Tax Rate (Quarter)
-0.00B